Hookworm Vaccine Trials Begin at GW

In a pioneering study, infecting healthy adults is the next step toward eradicating the infection. “These past few months have taught me a lot about hookworms, and it’s also given me intriguing insight into my own body and behaviors,” she said. Ms. Markowitz is one of the participants of the Hookworm Study. Check out this article to read more about Ms. Markowitz's experience.

 

Latest News

The GW VRU is proud to announce our newest publication to describe the development of a new Na-GST-1/Alhydrogel hookworm vaccine. This study showed promising results and can be read at the link below:
You are invited to attend the first featured presentation in the "State-of-the-Art Topics in Vaccinology" Seminar Series on Tuesday January 28, 2025 at 2 pm. by Dr. Nadine Rouphael, Executive Director of the Hope Clinic at the Emory Vaccine Center.
FDA Approves Abrysvo for Adults 18-59 at Increased Risk for RSV